These solutions highlight the industry’s shift to precision medicine. AI-driven adaptive cardiac devices are set to improve ...

MET-3 is under development for the treatment of hypertriglyceridemia. It comprises live microbiota that normally reside in the human gut of a healthy individual. It is administered through oral route ...

ABI-110 is under clinical development by Avirmax and currently in Phase II for Polypoidal Choroidal Vasculopathy.

President-elect Donald Trump’s threat to eliminate tax credits for electric vehicles likely gave plug-in cars a much-needed boost after a disappointing year, part of a broader surge in auto sales ...

As inflation continues to squeeze household budgets across the Asia-Pacific (APAC) region, consumers are increasingly turning ...

One prominent FDA-watcher said he sees no new regulations coming down in a new Trump administration, but he wondered if this was an opportunity to further reorganize food safety, possibly with a ...

Overall EV sales gained 12%, pushing the full-year total to a record 1.3 million, according to forecasts from researcher Cox Automotive.

The threat by President-elect Donald Trump to end tax credits for electric vehicles helped lift sales in the fourth quarter, ...

Immuno-oncology (IO) drugs or cancer therapeutics represent one of the most promising areas of medical innovation in the next five years, according to a report on Friday. The report by GlobalData, a ...

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

The “Instrument and Electrical Reliability Engineering (I&E RE)” position in Chevron’s ENGINE Centre (located in Bengaluru, ...

Prasanth Katam, an insurance analyst at GlobalData, noted that South Korea’s economy grew by only 1.4% in 2023, which ...